SCHEMBL658351

SCHEMBL658351

CCN(CC)c1ccc(C(c2ccc(N(CC)CC)cc2C)c2ccc(N(CC)CC)cc2C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100B P04271 1/20 0.51
GRK6 P43250 1/20 0.48
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
PKM P14618 1/20 0.43
HTT P42858 1/20 0.43
MCL1 Q07820 1/20 0.43
ALDH1A1 P00352 5/20 0.42
TSHR P16473 2/20 0.42
CYP3A4 P08684 3/20 0.41
MAPK1 P28482 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
PSMD14 O00487 1/20 0.41
RECQL P46063 1/20 0.41
GFER P55789 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TERT O14746 1/20 0.41
ATM Q13315 2/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10952039 0.98 S100B (0.53) S100BGRK6GAAMAPTPKM
SCHEMBL13804083 0.97 S100B (0.51) S100BGRK6GAAMAPTPKM
SCHEMBL656825 0.97 S100B (0.51) S100BGRK6GAAMAPTPKM
SCHEMBL10942423 0.94 S100B (0.46) S100BGRK6GAAMAPTPKM
SCHEMBL215745 0.93 S100B (0.49) S100BGRK6GAAMAPTPKM
SCHEMBL29371256 0.93 S100B (0.49) S100BGRK6GAAMAPTPKM
SCHEMBL7646626 0.92 MAPT (0.48) S100BGRK6GAAMAPTPKM
SCHEMBL13897298 0.92 S100B (0.47) S100BGRK6GAAMAPTPKM
SCHEMBL6248420 0.92 S100B (0.47) S100BGRK6GAAMAPTPKM
SCHEMBL5555826 0.92 S100B (0.47) S100BGRK6GAAMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9529286-B2 Antioxidants for overcoat layers and methods for making the same XEROX CORPORATION (US) 2016-12-27 US claimed
US-9500968-B2 Addition of non-networked hole transport molecule to fluorinated structured organic film for improved corona resistance XEROX CORPORATION (US) 2016-11-22 US claimed
US-20160231660-A1 ADDITION OF NON-NETWORKED HOLE TRANSPORT MOLECULE TO FLUORINATED STRUCTURED ORGANIC FILM FOR IMPROVED CORONA RESISTANCE XEROX CORPORATION 2016-08-11 US claimed
US-9075326-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2015-07-07 US claimed
US-20150102529-A1 ANTIOXIDANTS FOR OVERCOAT LAYERS AND METHODS FOR MAKING THE SAME XEROX CORPORATION (US) 2015-04-16 US claimed
US-8658337-B2 Imaging member layers XEROX CORPORATION (US) 2014-02-25 US claimed
US-20140023959-A1 IMAGING MEMBER LAYERS XEROX CORPORATION (US) 2014-01-23 US claimed
US-20130101929-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2013-04-25 US claimed
US-7501172-B2 Integrated recording and labeling with optical recording device HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2009-03-10 US claimed
US-7172991-B2 Integrated CD/DVD recording and labeling HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2007-02-06 US claimed
US-20060262178-A1 Integrated recording and labeling with optical recording device ANDERSON DARYL E 2006-11-23 US claimed
US-20030108708-A1 Integrated CD/DVD recording and labeling HEWLETT-PACKARD DEVELOPMENT COMPANY L.P. 2003-06-12 US claimed
EP-0767932-B1 LOW-VOLATILITY, SUBSTITUTED 2-PHENYL-4,6-BIS (HALOMETHYL)-1,3,5-TRIAZINE FOR LITHOGRAPHIC PRINTING PLATES PGI GRAPHICS IMAGING LLC (US) 2000-07-05 EP claimed
EP-0767932-A1 LOW-VOLATILITY, SUBSTITUTED 2-PHENYL-4,6-BIS (HALOMETHYL)-1,3,5-TRIAZINE FOR LITHOGRAPHIC PRINTING PLATES POLAROID CORPORATION (US) 1997-04-16 EP claimed
WO-1996034315-A1 LOW-VOLATILITY, SUBSTITUTED 2-PHENYL-4,6-BIS (HALOMETHYL)-1,3,5-TRIAZINE FOR LITHOGRAPHIC PRINTING PLATES POLAROID CORPORATION (US) 1996-10-31 WO claimed
US-5561029-A IMPROVED RESOLUTION AND PHOTOCURING, SHELF LIFE, PHOTOSTABILITY AND DEVELOPABILITY BY USING A BALLASTED 2-PHENYL-4,6-(HALOALKYL)-S-TRIAZINE PHOTOINITIATOR POLAROID CORPORATION (US) 1996-10-01 US claimed
US-4539282-A SENSITIZED ZINC OXIDE, POLYCARBONATE BINDER AND AROMATIC DIAMINE TOMOEGAWA PAPER MANUFACTURING COMPANY LIMITED (JP) 1985-09-03 US claimed
JP-57169759-A None JP disclosed
US-4251619-A Process for forming photo-polymeric image KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1981-02-17 US disclosed
US-4139390-A Presensitized printing plate having a print-out image EASTMAN KODAK COMPANY (US) 1979-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150102529-A1 ANTIOXIDANTS FOR OVERCOAT LAYERS AND METHODS FOR MAKING THE SAME LPO, MGMT, ABAT S100B 1480/4885GRK6 4320/4885GAA 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.